Story
A Phase I/II Study of a Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumours
This phase I/II clinical study will evaluate the ability of a new type of vaccine, Nous-209, in combination with another...
Gut microbiome signature identified in KRAS-mutated colorectal cancer patients
May 2024 According to a recent study published in Microbiology Spectrum, specific microbiome “signatures” were associated with KRAS mutations in...
Gut microbiome signatures may help unravel disparities in early-onset colorectal cancer
May 2024 A recent study published in the Journal of Immunotherapy and Precision Oncology suggests that the makeup of the...
Can Spending Time in Nature Help with Cancer and Treatment Symptoms and Side-Effects?
While treatment may be lifesaving, many folks experience a wide variety of treatment side-effects that lead to a reduction in...
Ongoing clinical trial: phase 3 study of perioperative dostarlimab in participants with untreated T4N0 or stage III dMMR/MSI-H resectable colon cancer (AZUR-2)
This study aims to investigate dostarlimab therapy in patients with locally advanced mismatch-repair deficient (dMMR) / microsatellite instability high (MSI-H) rectal cancer who have not received any previous treatment. Patients who achieve a complete clinical response (no detectable tumour remains)...
Caregiving for a Family Member Diagnosed with Cancer
Benefits of family support Family is one of the most important sources and support systems that patients have (Faraji et...
